PETROS PHARMACEUTICALS INC's ticker is PTPI and the CUSIP is 71678J100. A total of 24 filers reported holding PETROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $131,000 | +31.0% | 255,914 | +114.8% | 0.00% | – |
| Q2 2022 | $100,000 | -43.8% | 119,141 | +4.7% | 0.00% | – |
| Q1 2022 | $178,000 | -64.7% | 113,823 | -24.7% | 0.00% | – |
| Q4 2021 | $504,000 | +130.1% | 151,247 | +37.9% | 0.00% | – |
| Q3 2021 | $219,000 | -34.8% | 109,713 | +2.1% | 0.00% | – |
| Q2 2021 | $336,000 | +1.5% | 107,500 | +21.2% | 0.00% | – |
| Q1 2021 | $331,000 | +21.2% | 88,704 | +42.9% | 0.00% | – |
| Q4 2020 | $273,000 | – | 62,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 100,000 | $200,000 | 0.15% |
| Shay Capital LLC | 277,737 | $555,000 | 0.07% |
| EMFO, LLC | 28,000 | $56,000 | 0.05% |
| Platform Technology Partners | 44,000 | $88,000 | 0.04% |
| NorthRock Partners, LLC | 115,295 | $431,000 | 0.04% |
| NEVILLE RODIE & SHAW INC | 21,875 | $44,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,200 | $2,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 100 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 41 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |